Observational studyJournal of translational medicine2026

A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.

T S Ramasubramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.